General Biotechnology

Is That Daylight for ImClone? The beleaguered drugmaker finally gets some good news with Swiss approval of its cancer-fighting drug […]

Over the Rainbow Yet? Consolidation slows, valuations grow, and now hope for some IPOs

Ultimate Analysis With the necessary tools at hand, the race is on to build � and market � the first

COUNTERING COUNTERFEITS Industry offers proposals to fight growing problem of fake drugs.

BAYER CHEMICALS TO TAKE A SPIN Split-off of chemicals will shift firm�s focus to life sciences

BIOTECH SCORES BIG THIRD-QUARTER GAINS Substantial revenue and earnings growth continued unabated for yet another quarter

DRUG EARNINGS RALLY IN THE THIRD QUARTER Major pharmaceutical firms see improvement in sales and earnings as the year progresses

It Lives for 29 Years? A lawsuit filed April 11 in the U.S. District Court in Los Angeles has grabbed

Big pharma plays hard ball with little biotech If you play with the big boys you might get hurt…

USDA Sued Over Drug-Growing Crops A coalition of environmental groups and consumer advocates sued the U.S. Agriculture Department in federal